top of page
dreamstimemaximum_88001888_lower mb.jpg
icons_quality policy.png

Quality policy

“The focus of Tada Group is needs-based R&D. Our medical devices are based on research, design, development, manufacturing in accordance with Tada Group’s QMS and applicable regulatory requirements with focus on customer needs. Tada Group provides breakaway connectors to be used as value enhancing components for IV lines preventing catheter failure due to mechanical complications.”

ReLink / Link US

tada group relink working.gif

ReLink / LinkUS is a patented breakaway connector, designed to prevent mechanical complications such as dislodgement, thereby providing increased safety for patients and nurses. It comprises a weak link concept to reduce IV catheter dislodgement in combination with self-sealable valves to prevent spill of IV fluids, medicine, and blood.

Child-Hand-Good.jpg

Advantages for patients

  • Minimises risks of IV catheter complications such as dislodgement

  • Reduces patient injuries and risk for infections

  • Supports accurate drug delivery

AdobeStock_130573118 lower mb.jpg

Advantages for nurses

  • Reduces risk of toxic drug exposure

  • Reduces risk of blood exposure

  • Reduces unnecessary workload and unlocks valuable nursing hours

Catalogue

ReLink / LinkUS is a groundbreaking platform technology poised to redefine patient safety and healthcare efficiency. It sets a new standard in IV therapy—minimising medical errors, unlocking valuable nursing hours, and opening a multitude of opportunities.

ReLink Logos_care-03.png
ReLink Logos_vet-05.png

First generation single-use breakaway connector promoting increased safety for patient and healthcare professionals. CE approved for gravitational IV therapy.

dreamstime_xxl_59929888-lower mb.jpg
ReLink Logos_vet-05.png
Linkus logo_Vet H.png

IV catheter accessory for animal care. Suitable for companion animals and larger animals such as foals.

dreamstime_xxl_214526885_lower mb.jpg
ReLink Logos_drain.png
Linkus logo_Drain H.png

Dislodgement prevention tailored for pigtail nephrostomy catheters. The self-sealing valves prevent soiling of the bed and surrounding environment upon separation of the ReLink parts.

shutterstock_159603626_lower mb.jpg

Embracing the power of the ReLink technology

Our R&D team is working to extend the ReLink technology to cover also the following market segments.

ReLink Logos_digital-01.png

A digital add-on to the all-mechanical core ReLink technology will facilitate moving IV therapy from the hospital to the home, which could save up to 90% of treatment costs. 

dreamstime_xxl_132717305_lower mb.jpg
ReLink Logos_chemo-12.png

A closed system connector device that completely eliminates leakage of toxic liquids and vapours to safekeep healthcare professionals working with hazardous drugs such as chemotherapy.

shutterstock_1901756146 lower mb.jpg
ReLink Logos_antimicrobial-14.png

A ReLink functionalised with an antimicrobial barrier would be specially beneficial for immunocompromised patients and central line usage.

shutterstock_797729788 lower mb.jpg

Research support

The project has received funding from the European Union's Horizon 2020 research and innovation programme under EIC Accelerator grant, Fast Track to Innovation grant and from the Eurostars-2 Joint Programme with co-funding from the European Union's Horizon 2020 research and innovation programme

eithealth.png
1602248683_vinnovas-logotyp-i-farg-mellanupplost.png

Sustainability

Our innovation not only addresses healthcare and patient safety, but also the wider concerns of European and global importance as outlined in the 2030 agenda for sustainable development.

Annual Report 2022 v10-01_edited.jpg
Goal 3: Good health and well-being 

ReLink is a solution that disrupts the state-of-the-art of IV therapy. The elderly patients, psychiatric patients, as well as paediatric patients will particularly benefit from the improvements that ReLink offers.

Annual Report 2022 v10-02.jpg
Goal 6: Clean water and sanitation

ReLink aids in curbing hazardous chemical pollution, lowering medication wastage, and promoting affordable healthcare solutions, thus addressing global challenges and enhancing safety.

Annual Report 2022 v10-03.jpg
Goal 8: Decent work and economic growth

ReLink enhances global healthcare by saving time and costs, preventing spills, ensuring safety, and creating a positive working environment for healthcare professionals, while being adaptable for home care.

Annual Report 2022 v10-04.jpg
Goal 12: Responsible consumption and production

ReLink will align towards improper waste handling, not only for medicine and chemicals, but also by saving plastic waste annually in Europe and USA.

bottom of page